Australia markets closed

Orthocell Limited (OCC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3950+0.0150 (+3.95%)
At close: 02:29PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
1,532
4,243
1,532
1,018
719.523
Cost of revenue
702.61
1,026
702.61
625.645
505.374
Gross profit
829.108
3,217
829.108
392.317
214.149
Operating expenses
Research development
6,818
7,598
6,818
7,343
5,470
Selling general and administrative
5,535
5,959
5,535
4,718
3,999
Total operating expenses
12,702
14,112
12,702
12,497
9,730
Operating income or loss
-11,873
-10,895
-11,873
-12,105
-9,515
Total other income/expenses net
189.938
79.198
189.938
38.631
82.94
Income before tax
-11,251
-9,411
-11,251
-11,431
-9,056
Income tax expense
-2,144
-3,162
-2,144
-2,394
-2,905
Income from continuing operations
-9,107
-6,248
-9,107
-9,037
-6,151
Net income
-9,107
-6,248
-9,107
-9,037
-6,151
Net income available to common shareholders
-9,107
-6,248
-9,107
-9,037
-6,151
Basic EPS
-0.04
-0.03
-0.05
-0.05
-0.04
Diluted EPS
-0.04
-0.03
-0.05
-0.05
-0.04
Basic average shares
196,316
197,213
194,666
186,853
171,003
Diluted average shares
196,316
197,213
194,666
186,853
171,003